W. Keith Miskimins

2.7k total citations
69 papers, 2.3k citations indexed

About

W. Keith Miskimins is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, W. Keith Miskimins has authored 69 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Molecular Biology, 25 papers in Oncology and 14 papers in Cancer Research. Recurrent topics in W. Keith Miskimins's work include Cancer-related Molecular Pathways (18 papers), Cancer, Hypoxia, and Metabolism (11 papers) and Epigenetics and DNA Methylation (11 papers). W. Keith Miskimins is often cited by papers focused on Cancer-related Molecular Pathways (18 papers), Cancer, Hypoxia, and Metabolism (11 papers) and Epigenetics and DNA Methylation (11 papers). W. Keith Miskimins collaborates with scholars based in United States and South Korea. W. Keith Miskimins's co-authors include Yongxian Zhuang, Robin Miskimins, F.H. Ruddle, Nobuyoshi Shimizu, Alan McClelland, Qiou Wei, Daniel Chan, Joseph D. Coppock, Gang Greg Wang and Yuhuan Zheng and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

W. Keith Miskimins

69 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
W. Keith Miskimins United States 27 1.8k 577 520 231 192 69 2.3k
Robert Amson France 27 2.0k 1.1× 762 1.3× 475 0.9× 365 1.6× 98 0.5× 40 3.2k
Jessie M. English United States 19 2.2k 1.3× 496 0.9× 391 0.8× 221 1.0× 127 0.7× 24 2.9k
Carmen Page United States 8 1.9k 1.1× 779 1.4× 342 0.7× 408 1.8× 88 0.5× 8 2.5k
Dongmei Zuo Canada 27 1.6k 0.9× 385 0.7× 329 0.6× 214 0.9× 140 0.7× 54 2.2k
Masahiro Hitomi United States 30 2.1k 1.2× 1.2k 2.0× 632 1.2× 256 1.1× 161 0.8× 65 3.0k
Oleg N. Demidov France 26 2.0k 1.1× 997 1.7× 423 0.8× 224 1.0× 82 0.4× 54 2.6k
Brigitte Sola France 28 1.3k 0.7× 485 0.8× 209 0.4× 368 1.6× 93 0.5× 101 2.2k
Kathrin Gottlob United States 7 2.0k 1.1× 291 0.5× 648 1.2× 221 1.0× 211 1.1× 7 2.4k
Lydia Puricelli Argentina 26 901 0.5× 551 1.0× 489 0.9× 238 1.0× 84 0.4× 68 1.8k
Jee‐Yin Ahn South Korea 26 1.2k 0.7× 297 0.5× 146 0.3× 309 1.3× 161 0.8× 77 2.0k

Countries citing papers authored by W. Keith Miskimins

Since Specialization
Citations

This map shows the geographic impact of W. Keith Miskimins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. Keith Miskimins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. Keith Miskimins more than expected).

Fields of papers citing papers by W. Keith Miskimins

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W. Keith Miskimins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. Keith Miskimins. The network helps show where W. Keith Miskimins may publish in the future.

Co-authorship network of co-authors of W. Keith Miskimins

This figure shows the co-authorship network connecting the top 25 collaborators of W. Keith Miskimins. A scholar is included among the top collaborators of W. Keith Miskimins based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W. Keith Miskimins. W. Keith Miskimins is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Puente, Pilar de la, et al.. (2022). Reduction of Metastasis via Epigenetic Modulation in a Murine Model of Metastatic Triple Negative Breast Cancer (TNBC). Cancers. 14(7). 1753–1753. 12 indexed citations
3.
Powell, Steven, Miroslaw Mazurczak, Elie G. Dib, et al.. (2022). Phase II study of dichloroacetate, an inhibitor of pyruvate dehydrogenase, in combination with chemoradiotherapy for unresected, locally advanced head and neck squamous cell carcinoma. Investigational New Drugs. 40(3). 622–633. 44 indexed citations
5.
Powell, Steven, William C. Spanos, Lora Black, et al.. (2015). Phase II study of dichloroacetate (DCA) in combination with chemoradiation (CRT) for unresected, locally advanced squamous cell carcinoma of the head and neck (LA-SCCHN).. Journal of Clinical Oncology. 33(15_suppl). e17089–e17089. 3 indexed citations
6.
Zhuang, Yongxian, Daniel Chan, & W. Keith Miskimins. (2014). Preventing feedback activation of glycolytic ATP production enhances metformin cytotoxicity in breast cancer cells when oxidative phosphorylation is inhibited. Cancer & Metabolism. 2(S1). 1 indexed citations
7.
Miskimins, W. Keith, et al.. (2014). Synergistic Anti-Cancer Effect of Phenformin and Oxamate. PLoS ONE. 9(1). e85576–e85576. 116 indexed citations
8.
Zhuang, Yongxian & W. Keith Miskimins. (2011). Metformin Induces Both Caspase-Dependent and Poly(ADP-ribose) Polymerase-Dependent Cell Death in Breast Cancer Cells. Molecular Cancer Research. 9(5). 603–615. 96 indexed citations
9.
Coleman, Jennifer & W. Keith Miskimins. (2009). Structure and activity of the internal ribosome entry site within the human p27Kip1 5’-untranslated region. RNA Biology. 6(1). 84–89. 16 indexed citations
10.
Wei, Qiou, W. Keith Miskimins, & Robin Miskimins. (2005). Stage-specific Expression of Myelin Basic Protein in Oligodendrocytes Involves Nkx2.2-mediated Repression That Is Relieved by the Sp1 Transcription Factor. Journal of Biological Chemistry. 280(16). 16284–16294. 62 indexed citations
11.
Coleman, Jennifer, et al.. (2003). Expression of constitutively active 4EBP-1 enhances p27Kip1 expression and inhibits proliferation of MCF7 breast cancer cells. Cancer Cell International. 3(1). 2–2. 44 indexed citations
12.
Clark, Robert E., W. Keith Miskimins, & Robin Miskimins. (2002). Cyclic AMP inducibility of the myelin basic protein gene promoter requires the NF1 site. International Journal of Developmental Neuroscience. 20(2). 103–111. 11 indexed citations
13.
Coleman, Jennifer, et al.. (2001). The major transcription initiation site of the p27 Kip1 gene is conserved in human and mouse and produces a long 5'-UTR. BMC Molecular Biology. 2(1). 12–12. 19 indexed citations
14.
Wang, Gang Greg, Robin Miskimins, & W. Keith Miskimins. (2000). Mimosine Arrests Cells in G1 by Enhancing the Levels of p27Kip1. Experimental Cell Research. 254(1). 64–71. 57 indexed citations
15.
Miskimins, Robin, et al.. (1999). ATF-1 Is Activated in Response to UV Irradiation in B16 Melanoma Cells. PubMed. 1(1). 1–6. 1 indexed citations
16.
Miskimins, W. Keith, et al.. (1997). Cyclin-dependent kinase inhibitor P27kip1 is expressed at high levels in cells that express a myelinating phenotype. Journal of Neuroscience Research. 50(3). 373–382. 24 indexed citations
17.
Miskimins, W. Keith & David B. Brown. (1990). Analysis of cis-acting promoter elements using microinjected synthetic oligonucleotides. Experimental Cell Research. 191(2). 328–331. 5 indexed citations
18.
Roberts, Michelle, W. Keith Miskimins, & F.H. Ruddle. (1989). Nuclear proteins TREF1 and TREF2 bind to the transcriptional control element of the transferrin receptor gene and appear to be associated as a heterodimer.. PubMed. 1(1). 151–164. 47 indexed citations
19.
Miskimins, W. Keith, Wayne Ferris, & Nobuyoshi Shimizu. (1981). Genetics of receptors for bioactive polypeptides: A variant of swiss/3T3 fibroblasts resistant to a cytotoxic insulin accumulates lysosome‐like vesicles. PubMed. 16(1). 105–113. 8 indexed citations
20.
Miskimins, W. Keith & Nobuyoshi Shimizu. (1979). Synthesis of a cytotoxic insulin cross-linked to diphtheria toxin fragment a capable of recognizing insulin receptors. Biochemical and Biophysical Research Communications. 91(1). 143–151. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026